The World Health Organization declared the Ebola outbreak affecting the Democratic Republic of Congo and Uganda a public health emergency of international concern on May 17, 2026, after the death toll climbed to 88 and the number of suspected cases surpassed 300.
What makes this outbreak especially troubling for health officials is the specific strain responsible: the Bundibugyo virus, a rare variant of Ebola for which there are currently no approved vaccines or therapeutic treatments. Unlike the better known strains that have driven previous outbreaks, this one leaves medical teams with significantly fewer tools to fight back.
Despite the severity of the situation, the WHO was careful to note that conditions do not meet the threshold for a pandemic emergency on the scale of COVID-19, and the organization has advised against the closure of international borders, stressing the need to balance public health protections with the continued flow of travel and trade.
Where the outbreak began
The outbreak originated in Ituri, a province in eastern Congo situated near the borders of both Uganda and South Sudan a geographic position that health officials say increases the risk of cross border transmission.
Health authorities confirmed the spread of the disease on May 15, 2026, and within a day, the Africa Centres for Disease Control and Prevention had documented 336 suspected cases and 87 deaths across the region. Congo accounts for the vast majority of those cases, but Uganda has not been spared.
Two cases have now been confirmed in Uganda, both traced back to individuals who traveled from Congo. One of those patients died at a hospital in Kampala, the Ugandan capital. A second case was subsequently reported in the same city. What particularly concerned health officials was that the two Kampala cases had no apparent connection to each other, raising the possibility of broader, harder to trace community spread.
A virus seen only twice before
The Bundibugyo virus has an unusually brief and troubling history. It was first identified during an outbreak in Uganda’s Bundibugyo district between 2007 and 2008, when it infected 149 people and killed 37. The second recorded occurrence came in 2012, in the town of Isiro in Congo, where 57 people were infected and 29 died.
That limited history means scientists and health workers have had relatively few opportunities to study the strain, develop countermeasures, or build response protocols specifically tailored to it a gap that is now coming into sharp focus.
How health authorities are responding
The WHO is working alongside local health officials in both Congo and Uganda to monitor the outbreak and enforce containment measures. International health agencies are also ramping up support to help governments manage the surge in suspected cases.
Public health experts are focused on several fronts: expanding surveillance to detect and report new cases more quickly, launching community awareness efforts so people can recognize symptoms and seek care early, and reinforcing healthcare infrastructure in affected areas to ensure facilities are equipped to handle a continued rise in patients. Cross border coordination between Congo, Uganda, and neighboring South Sudan is also a central priority, with authorities working to share data and resources in real time.
Ebola spreads through direct contact with the blood or bodily fluids of an infected person, and symptoms typically include fever, severe headache, muscle pain, vomiting, and unexplained bleeding. Early detection and isolation remain the most effective tools available, particularly for a strain without an approved vaccine.
What this means going forward
The WHO’s emergency declaration is intended to mobilize faster international support and funding, not to trigger travel bans or border closures. Officials are urging countries to remain engaged and cooperative rather than retreat behind restrictions that could hinder the movement of medical personnel and supplies into affected areas.
The outbreak serves as a sobering reminder that the Democratic Republic of Congo, which has experienced more Ebola outbreaks than any other country in the world, continues to face enormous challenges in containing a disease that has proven deeply difficult to eradicate from the region. With no vaccine on the horizon for the Bundibugyo strain and cases now appearing in a major capital city, the coming weeks will be critical.
